Lee Financial’s Zymeworks ZYME Stock Holding History

Lee Financial’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-100	Closed	-$1K	–	510
2017 Q3	$1K	Hold	100	–	–	﹤0.01%	467
2017 Q2	$1K	Buy	+100	New	+$1.12K	﹤0.01%	490

Other funds holding ZYME

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Lee Financial's ZYME Position: Q4 2017 in Review

Lee Financial sold out of Zymeworks (ZYME) in Q4 2017, closing a stake of 100 shares — an estimated $1K sold.

Lee Financial first reported a position in ZYME in Q2 2017 and held it in 2 quarters. The position peaked at $1K in Q3 2017. 15 funds tracked by Wall St. Rank hold ZYME as of Q4 2017.

Lee Financial reported no remaining Zymeworks position as of Q4 2017 after selling out during the quarter.
Lee Financial sold 100 Zymeworks shares in Q4 2017, an estimated $1K.
Lee Financial first reported a position in Zymeworks in Q2 2017 and held it in 2 quarters.
Lee Financial's Zymeworks position peaked at $1K in Q3 2017.
15 funds tracked by Wall St. Rank held Zymeworks as of Q4 2017.

Based on Lee Financial's 13F filing for Q4 2017, filed 9 Feb 2018.